[Long-term study of the significance of hormone receptors as prognostic factors in breast cancer]. 1990

E Merkle, and I Seidl, and I Bähr, and A H Tulusan, and K von Maillot, and K W Sauerbrei, and P M Wirtz
Universitätsfrauenklinik Erlangen.

To check the question as to the prognostic significance of oestrogen and progesterone receptors in invasive breast cancer, the course of the disease was registered in 660 patients in the context of a retrospective study. These patients had been operated on with the objective of curing breast cancer between 1976 and 1984. A receptor analysis of these patients is available with regard to both receptor types. Positive progesterone receptors could be detected in 38%, positive oestrogen receptors in 70%. Values over 15 fmol/mg tissue protein were rated as positive. The proportion of oestrogen-receptor-positive tumours increased with the age of the patients. On the other hand, the progesterone receptor did not show this dependence. During analysis of the median receptor concentrations as well as of the progesterone combinations, a correlation between the axillary lymph node status and the hormone receptor status of the primary tumour could not be observed for the two receptor types. The survival time in relation to the oestrogen receptor status did not indicate any significant effect on survival time. On the other hand, the improvement of survival time depending on the positive progesterone receptor status was highly significant in statistical terms (p less than 0.001) especially in nodal-positive patients. Both patients with axillary lymph node metastases and positive progesterone status, compared with patients without lymph node invasion and a negative progesterone status, had the same survival rate.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009376 Neoplasms, Hormone-Dependent Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment. Hormone-Dependent Neoplasms,Hormone Dependent Neoplasms,Hormone-Dependent Neoplasm,Neoplasm, Hormone-Dependent,Neoplasms, Hormone Dependent
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D001940 Breast In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES. Breasts
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

E Merkle, and I Seidl, and I Bähr, and A H Tulusan, and K von Maillot, and K W Sauerbrei, and P M Wirtz
December 1991, Annals of medicine,
E Merkle, and I Seidl, and I Bähr, and A H Tulusan, and K von Maillot, and K W Sauerbrei, and P M Wirtz
March 1988, The Mount Sinai journal of medicine, New York,
E Merkle, and I Seidl, and I Bähr, and A H Tulusan, and K von Maillot, and K W Sauerbrei, and P M Wirtz
January 1986, NCI monographs : a publication of the National Cancer Institute,
E Merkle, and I Seidl, and I Bähr, and A H Tulusan, and K von Maillot, and K W Sauerbrei, and P M Wirtz
May 1983, American journal of surgery,
E Merkle, and I Seidl, and I Bähr, and A H Tulusan, and K von Maillot, and K W Sauerbrei, and P M Wirtz
January 2017, American journal of cancer research,
E Merkle, and I Seidl, and I Bähr, and A H Tulusan, and K von Maillot, and K W Sauerbrei, and P M Wirtz
April 1993, Der Gynakologe,
E Merkle, and I Seidl, and I Bähr, and A H Tulusan, and K von Maillot, and K W Sauerbrei, and P M Wirtz
January 2010, MEDICC review,
E Merkle, and I Seidl, and I Bähr, and A H Tulusan, and K von Maillot, and K W Sauerbrei, and P M Wirtz
February 1993, Cancer,
E Merkle, and I Seidl, and I Bähr, and A H Tulusan, and K von Maillot, and K W Sauerbrei, and P M Wirtz
January 1986, Breast cancer research and treatment,
E Merkle, and I Seidl, and I Bähr, and A H Tulusan, and K von Maillot, and K W Sauerbrei, and P M Wirtz
April 1998, Bulletin du cancer,
Copied contents to your clipboard!